Does glutathione treatment work?
Glutathione has a real role in the body. Whether taking it improves a specific symptom depends on the route, population and outcome studied.
A human trial with a specific question
A phase IIb study tested intranasal glutathione in people with Parkinson disease. Neither active-treatment group was superior to placebo. This does not establish a general benefit for energy, recovery or the subcutaneous product offered here.
Read: Mischley et al. Intranasal glutathione in Parkinson disease.
Why an antioxidant label is not enough
Describing a molecule as an antioxidant explains part of its biology. It does not show that more of it improves how a person feels. A change in a blood measurement and a meaningful symptom improvement are different outcomes.
Choosing among injection, nasal spray and supplements
Ask what evidence applies to your goal and the specific route. Convenience matters, but there is no clinical ranking in the cited trial that makes an injection automatically better. Agree on what will be measured and when to reassess instead of assuming every route has the same effects.
Sources
- Mischley et al. Intranasal glutathione in Parkinson disease
Journal of Parkinson’s Disease, 2017. Phase IIb trial; active groups not superior to placebo.
- FDA: Compounding questions and answers
The distinction between compounded medications and FDA-approved drug products.
